An RBD virus-like particle vaccine for SARS-CoV-2 induces cross-variant antibody responses in mice and macaques

被引：0
作者：
Yuanyuan Li
Yanan Zhang
Yu Zhou
Yan Li
Jiao Xu
Yuanbao Ai
Lei Xu
Xiuli Xiao
Bo Zhang
Jing Jin
机构：
[1] Patronus Biotech Co. Ltd.,Key Laboratory of Special Pathogens and Biosafety
[2] Wuhan Institute of Virology,undefined
[3] Center for Biosafety Mega-Science,undefined
[4] Chinese Academy of Sciences,undefined
来源：
Signal Transduction and Targeted Therapy | / 8卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 8 条
  • [1] Khoury DS(2021)Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection Nat. Med. 27 1205-1211
  • [2] Ward BJ(2021)Phase 1 randomized trial of a plant-derived virus-like particle vaccine for COVID-19 Nat. Med. 27 1071-1078
  • [3] Fougeroux C(2021)Capsid-like particles decorated with the SARS-CoV-2 receptor-binding domain elicit strong virus neutralization activity Nat. Commun. 12 1544-1555
  • [4] Corbett KS(2020)Evaluation of the mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates N. Engl. J. Med. 383 283-289
  • [5] Vogel AB(2021)BNT162b vaccines protect rhesus macaques from SARS-CoV-2 Nature 592 578-582
  • [6] van Doremalen N(2020)ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques Nature 586 1058-1071
  • [7] An Y(2022)A tandem-repeat dimeric RBD protein-based covid-19 vaccine zf2001 protects mice and nonhuman primates Emerg. Microbes Infect. 11 77-81
  • [8] Gao Q(2020)Development of an inactivated vaccine candidate for SARS-CoV-2 Science 369 undefined-undefined
1